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ABSTRACT
 
We report two cases of cutaneous B-cell pseudolymphoma (PCBCL) induced by intradermal antigen
injections for specific immune therapy (SIT). In both cases, the lesions had first developed on the area of
injection; years later, new lesions appeared far from the original site. The histological, immunohistochemical,
and molecular findings of the lesions showed features consistent with the diagnosis of PCBCL in both cases.
In particular, the staining for sIg light chains showed a polyclonal pattern, and the molecular analysis by
reverse transcriptase-polymerase chain reaction (RT-PCR) and Southern blot showed a germ-line configu-
ration of the Ig heavy chain genes. While the development of PCBCL related to a specific stimulus is well
known and widely reported, the development of histologically and immunohistologically identical lesions
far from the injection site is definitely worthy of note. This behaviour might be due to the presence of
retained antigens in the injection site. This chronic antigenic stimulation could induce the progressive
selection – and subsequent dissemination – of antigen-specific B cell clones.
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Introduction
 
Cutaneous B-cell pseudolymphoma (PCBCL), otherwise
known as cutaneous lymphoid hyperplasia (CLH), is a reactive
B-cell hyperplasia that clinically and histologically mimics
cutaneous B-cell lymphoma (CBCL).
 
1–4
 
 Both primary cutaneous
B-cell lymphoma (CBCL) and PCBCL share indolent clinical
course and good response to non-aggressive treatment,
therefore, these features are not crucial in the differential
diagnosis. According to a widely accepted opinion, the only key
diagnostic criteria to date are the demonstration of clonality (by
immunohistochemistry and/or molecular analysis) and/or the
correlation with known environmental stimuli: insect or
arthropod bites, tattoos, infection by 
 
Borrelia burgdorferi
 
.
 
5–10
 
In these latter conditions, skin lesions usually arise on the area
affected by the specific trigger.
In this paper, we report two cases of PCBCL induced by sub-
cutaneous antigen injections (specific immune therapy, SIT) in
which, years later, the dissemination of lesions far from the
injection site did occur.
 
Case reports
 
Case 1
 
A 30-year-old woman presented with erythemato-cyanotic
plaques and nodules located on the lateral surface of both arms
(fig. 1a), left buttock and left thigh (fig. 1b). The lesions of the
arms had been present for 10 years, and developed soon after
SIT by the coalescence of small papules and nodules. The
patient had a family and personal history of atopy (rhinitis,
atopic dermatitis). Total IgE and specific IgE for Parietaria and
Graminaciae were increased, and prick tests for these latter
allergens were positive. In addition, the patient was sensitized to
nickel sulphate. The lesions on the left thigh and buttock had
developed approximately 2 years before our observation.
A previous biopsy, taken from the right arm in another hospital,
showed a dermal nodular lymphohystiocytic infiltrate with
typical lymphoid follicles. A complete staging was carried out,
including bone marrow biopsy, without any pathologic
findings. New samples from both left arm and left thigh
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lesions were taken and processed for routine histology, immu-
nohistochemistry (fixed/embedded and frozen tissue), and
molecular analysis. The histology showed the same pattern in
both examined lesions: nodular and diffuse lymphohystiocytic
infiltrate in the superficial and mid dermis, with presence of
numerous typical reactive lymphoid follicles (figs 2,3). Immu-
nohistochemical staining on paraffin sections showed that reac-
tive follicles were mostly CD20+, although they occasionally
harboured scattered CD3+ T-lymphocytes (fig. 4). The inter-
follicular areas were rich in T-lymphocytes (fig. 4), with isolated
or small groups of B cells and CD68+ histiocytes. The reactive
germinal centres were bcl-2 negative, contrasting with the pos-
itive cells in the mantles and interfollicular areas (fig. 5). The
immunohistochemical analysis (APAAP technique) on frozen
sections showed a mixed B- and T-cell infiltrate, with a distinct
compartmentalization: nodular aggregates with typical features
of secondary lymphoid follicles (CD22+ B cells with a CD5-/
CD10+ phenotype associated with CD35+ follicular dendritic
cells in the germinal centre; in the mantle, CD22+ B cells with
CD5+/CD10- [mantle cell] or CD5-/CD10- [marginal cell]
phenotype) were irregularly surrounded by ‘interfollicular’
areas in which CD3+, CD4+ T-cells and CD22+, CD5-, CD10-
B cells were strictly intermingled. The staining for sIg light
chains showed a polyclonal pattern (kappa/lambda ratio 4 : 1)
in both areas. This finding was essential to establish the diagno-
sis of PCBCL. The molecular analysis by reverse transcriptase–
polymerase chain reaction (RT-PCR) and Southern blot showed
a germ-line configuration of the immunoglobulin heavy chain
genes.
 
Case 2
 
A 47-year-old female presented in our Department with
pigmented plaques on the lateral surface of both arms, thighs,
buttocks and lower back. The lesions of the arms had
developed, initially as grouped papules and small nodules, soon
after SIT performed 18 years before. One year later, due to the
persistence of such lesions, the patient was treated in another
fig. 1 (a) Patient 1. Erithematous and pigmented plaque on the lateral
surface of left arm, site of previous (10 years) specific immune therapy.
(b) Patient 1. Erythematous plaque of the left thigh. This and other skin
lesions (left buttock) had developed approximately 8 years after that shown
in fig. 1.
fig. 2 Patient 1, left thigh. Nodular and diffuse lymphohystiocytic infiltrate
in the upper-mid reticular dermis, with presence of typical reactive lymphoid
follicles (H&E, original magnification ·  40).
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centre by local radiotherapy with no improvement. To follow,
she was treated by intralesional corticosteroids, with eventu-
ation in thinner, pigmented plaques. The lesions on the thighs,
buttocks and back had appeared about 2 years later as itching,
pigmented and infiltrated plaques. The patient reported a
20-year-history of rhinitis and conjunctivitis induced by
Graminaciae. Total IgE were highly increased (963 UI/mL),
as well as specific IgE for Graminaciae. Prick tests were also
positive.
A biopsy taken in another centre from lesions of the left arm
showed a nodular and diffuse lymphohystiocitic infiltrate
composed by T and B cells, these latter organized in typical
lymphoid follicles with germinal centres in the mid and deep
dermis. New biopsy specimens taken from both right arm and
back were processed for histology, immunohistochemistry
and molecular analysis. The histology showed the same
pattern in both examined lesions: nodular lymphohystiocytic
infiltrate in the superficial and mid dermis, with no evidence of
histologically typical lymphoid follicles. The immunohistochemical
analysis on frozen sections showed a single typical, secondary
lymphoid follicle, irregularly surrounded by an infiltrate whose
features were not different from those observed in the interfol-
licular areas in case 1. The staining for sIg light chains showed a
polyclonal pattern (kappa/lambda ratio 3 : 1) in both follicular
and perifollicular areas. The molecular analysis by RT-PCR
and Southern blot showed a germ-line configuration of the
immunoglobulin heavy chain genes.
 
Discussion
 
The interest of our cases essentially concerns the occurrence of
new lesions far from the injection site of SIT some years after the
development of primary lesions at the injection site. Indeed,
cases of PCBCL resulting from antigen injections (pneumo-
allergens) for SIT and limited to the injection site have been
previously reported.
 
11,12
 
 In the cases reported herein, secondary
lesions did not show any histological, immunohistological and
molecular difference as compared to the primary ones.
fig. 3 Reactive lymphoid follicles were composed of a central, pale staining
germinal centre surrounded by a corona of small lymphocytes comprising
the mantle zone (H&E, original magnification ·  100).
fig. 4 Immunohistochemical stain for CD3 shows that reactive lymphoid fol-
licles occasionally harbour scattered CD3+ T-lymphocytes. These latter are
clearly prevalent in interfollicular areas (APAAP, original magnification ·  100).
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We might argue that SIT antigen(s) produce(s) a progressive
selection of antigen-specific B cell clones, which subsequently
spread from regional nodes to peripheral blood. These cells,
which reasonably retain their skin-homing properties, can be
recruited in the skin sites of contact with these airborne allergens.
The above hypothesis, i.e. continuous antigenic stimulus
producing selection and subsequent ‘dissemination’ of antigen-
specific B cell clones, could explain the occurrence of dissemi-
nated B-cell pseudolymphoma.
 
13,14
 
 Conversely, the cases
reported here do not support the hypothesis, suggested and
debated in the literature, of the progression of true PCBCL to
CBCL.
 
6,15–17
 
 In this regard, the development of CBCL related to
 
Borrelia burgdorferi
 
 infection
 
9,10
 
 is also particularly worthy of
attention, due to close similarity between the concepts of
 
Helicobacter pylori
 
 infection 
 
fi
 
 acquired MALT (Mucosa-
Associated Lymphoid Tissue)/MALT gastritis 
 
fi
 
 MALT
lymphoma on one hand, and of 
 
Borrelia burgdorferi
 
 infection
 
fi
 
 acquired SALT (Skin-Associated Lymphoid Tissue)/PCBCL
 
fi
 
 CBCL.
 
18–20
 
 The hypothesis of a different sequential develop-
ment of immune events related to SIT as compared to bacterial
infections like those from 
 
Borrelia burgdorferi
 
 and 
 
Helicobacter
pylori
 
, with a lower likelihood to eventuate into (immune)
dysplasia and neoplasia, can be reasonably suggested.
Speculations apart, it is a fact that we did not observe any his-
tologic, immunohistologic and/or molecular signs of aberrancy
in the lesions which had developed years after the primary ones
far from the injection site, e.g. dendritic cells ‘skipping’ the
germinal centre of reactive follicles, ‘invasion’ of reactive follicles
by neoplastic cells of the interfollicular areas, or clonal
rearrangement of Ig heavy chains.
 
5,6,15–17,19,20
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